Insiders · CINC

CINC insider transactions

CinCor Pharma Inc. (CINC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

CINC insiders

Everyone who has filed a Form 3, 4, 5 or 144 at CinCor Pharma Inc., latest first. Follow anyone to get their next filing.

• 5AM Partners VI, LLC10% owner+$18M
• James HealyDirector, 10% owner+$15.2M-$85.9K
• Mason FreemanOfficer-$91.26
• David D. AllisonDirector
• Troy A. IgnelziDirector
• Michael Wayne KalbOfficer, since November 2022
• June LeeDirector
• Catherine PearceOfficer
• John F TheroDirector
• Marc de GaridelOfficer, Director
• Sofinnova Partners SAS10% owner+$4M
• Sofinnova Venture Partners X, L.P.10% owner+$15M
• General Atlantic, L.P.10% owner+$2.49M
• General Atlantic Genpar (bermuda), L.P.10% owner+$2.49M

Recent Form 3, 4, and 5 filings for CINC

• 1350d
  SEC Form 4 filed by 5am Partners Vi, Llc

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1351d
  SEC Form 4: Healy James returned 19,608 shares to the company and sold $85,920 worth of shares (6,000 units at $14.32), closing all direct ownership in the company

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1351d
  SEC Form 4: Freeman Mason returned 40,000 shares to the company and sold $91 worth of shares (6 units at $15.21), closing all direct ownership in the company to satisfy withholding tax

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4 filed by Ignelzi Troy A.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4: Kalb Michael Wayne returned 202,437 shares to the company, closing all direct ownership in the company

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4 filed by Lee June

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4: Pearce Catherine returned 15,000 shares to the company, closing all direct ownership in the company (tax withholding)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4 filed by Thero John F

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1354d
  SEC Form 4: De Garidel Marc returned 200,000 shares to the company, closing all direct ownership in the company to cover taxes

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1379d
  SEC Form 4: De Garidel Marc was granted 200,000 shares, increasing direct ownership by 1,600% to 212,500 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1379d
  SEC Form 4: Pearce Catherine was granted 15,000 shares, increasing direct ownership by 11% to 155,149 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1379d
  SEC Form 4: Kalb Michael Wayne was granted 177,000 shares, increasing direct ownership by 696% to 202,437 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1379d
  SEC Form 4: Freeman Mason was granted 40,000 shares, increasing direct ownership by 1,600% to 42,500 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1390d
  SEC Form 4: Pearce Catherine converted options into 13,235 shares and covered exercise/tax liability with 3,997 shares, increasing direct ownership by 7% to 140,149 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1399d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1462d
  SEC Form 4: Kalb Michael Wayne was granted 25,437 shares

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1462d
  SEC Form 3 filed by new insider Kalb Michael Wayne

  3 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1489d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1545d
  SEC Form 4: 5am Partners Vi, Llc bought $18,000,000 worth of shares (600,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1545d
  SEC Form 4: Sofinnova Partners Sas bought $3,999,990 worth of shares (133,333 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1547d
  SEC Form 4: Sofinnova Venture Partners X, L.P. bought $15,000,000 worth of shares (500,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1547d
  SEC Form 4: Healy James bought $15,180,000 worth of shares (506,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1547d
  SEC Form 4: General Atlantic, L.P. bought $2,490,000 worth of shares (83,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1547d
  SEC Form 4: General Atlantic Genpar (Bermuda), L.P. bought $2,490,000 worth of shares (83,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1554d
  SEC Form 4: Healy James exercised 29,411 shares at a strike of $13.60

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1573d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1573d
  SEC Form 4 filed by Allison David D. (Amendment)

  4/A - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1643d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)